|
|
Article: American acne & rosacea society rosacea medical management guidelines.
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- June 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Objectives
The objectives of these Guidelines are to provide an overview of the fundamental disease state of rosacea and quality of life implications and outline available pharmacological treatments for rosacea with reference to supporting research and literature. The pharmacological agents discussed are inclusive of those that are FDA-approved based on phase 3 pivotal trials, commonly used agents based on extensive clinical experience, and less commonly used alternatives reported in peer-reviewed literature.
Disease State Fundamentals
A. A common facial disorder presenting most commonly in adulthood, estimated to affect approximately 14 mil ...
Related newspaper, magazine, and journal articles:
|
|
Article: Results of Large Phase IV Study Show Differin(R) (adapalene gel) ...
PR Newswire;
March 3, 2006 ;
700+ words
...- Patients Consider Differin as Part of an Acne Regimen Superior to Previous Acne Treatments - SAN FRANCISCO, March 3 /PRNewswire/ -- Findings from the M.O.R.E. (Measuring Outcomes in A Real World Experience) Trial presented today at the 64th annual meeting of the American Academy of Dermatology
|
|